COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis

Authors: Roland Linder, Jonas Peltner, Anatoli Astvatsatourov, Willy Gomm, Britta Haenisch

Source: BMC Public Health, Vol 25, Iss 1, Pp 1-14 (2025)

Subject Terms: Case-control study, COVID-19, Coronavirus, SARS-CoV-2, Epidemiology, Claims data, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2458

Access URL: https://doaj.org/article/aee690bee76648fa93d7e2a0679e5568

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis

Authors: Ralph Mösges, Antonio Valero Santiago, Silke Allekotte, Nilufar Jahed, Anatoli Astvatsatourov, Angelika Sager, Jaime Sánchez-López

Source: Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-15 (2019)

Subject Terms: Allergen immunotherapy, Allergic rhinoconjunctivitis, Bronchial asthma, Meta-analysis, Product-specific, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13601-019-0268-5; https://doaj.org/toc/2045-7022

Access URL: https://doaj.org/article/b07c9930d31642fa80f5de13e7252bd9

Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy

Authors: Janina Köther, Alicia Mandl, Silke Allekotte, Anatoli Astvatsatourov, Janin Chwieralski, Jan-Patrick Liedtke, Ursula Pieper-Fürst, Esther Raskopf, Kija Shah-Hosseini, Ralph Mösges

Source: Clinical and Translational Allergy, Vol 8, Iss 1, Pp 1-11 (2018)

Subject Terms: Conjunctival provocation test, Conjunctival allergen challenge, Early responder, Sublingual immunotherapy, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13601-018-0214-y; https://doaj.org/toc/2045-7022

Access URL: https://doaj.org/article/4cc8c0140d3042f9a78d710316aa854d